Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Thomas Berthold |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [h215o]-positron emission tomography study / Alex Gamma en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)
[artículo]
Título : No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [h215o]-positron emission tomography study Tipo de documento: texto impreso Autores: Alex Gamma, Autor ; Alfred Buck, Autor ; Thomas Berthold, Autor Fecha de publicación: 2023 Artículo en la página: pp. 66-71 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Excitación, Cerebro - diagnóstico por imágenes, Cerebro - fisiología, Cognición, Depresión, Alucinógenos, Radioisótopos de oxígeno, Trastornos relacionados con sustancias. Resumen: The long-term use of the serotonin-releaser and uptake-inhibitor 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been associated with memory impairments and increased liability to depressive mood and anxiety attacks. It is unclear, however, whether these psychologic deviations are reflected in alterations of the underlying neurophysiologic substrate. Link: ./index.php?lvl=notice_display&id=31139
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 66-71[artículo] No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [h215o]-positron emission tomography study [texto impreso] / Alex Gamma, Autor ; Alfred Buck, Autor ; Thomas Berthold, Autor . - 2023 . - pp. 66-71.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 66-71
Palabras clave: Excitación, Cerebro - diagnóstico por imágenes, Cerebro - fisiología, Cognición, Depresión, Alucinógenos, Radioisótopos de oxígeno, Trastornos relacionados con sustancias. Resumen: The long-term use of the serotonin-releaser and uptake-inhibitor 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been associated with memory impairments and increased liability to depressive mood and anxiety attacks. It is unclear, however, whether these psychologic deviations are reflected in alterations of the underlying neurophysiologic substrate. Link: ./index.php?lvl=notice_display&id=31139